Stock 2186 LUYE PHARMA GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Luye Pharma Group Ltd.

Equities

2186

BMG570071099

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
2.72 HKD +0.74% Intraday chart for Luye Pharma Group Ltd. +4.21% -27.08%
Mar. 27 Luye Pharma Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 07 Luye Pharma Group Announces the Launch of Its Innovative Drug Zepzelca® (Lurbinectedin) for the Treatment of SCLC in Both Hong Kong and Macao CI

Evolution of the average Target Price on Luye Pharma Group Ltd.

Price target over the last 5 years

History of analyst recommendation changes

0b8ab329392f72c7e4b8439aaa3cf7e._h2TEkNOhrdQmzPcWnBjnLmThlWwRvE6CphTT--OaVw.uXzSWgYpx4dgwXWwKx4L1ObyvmLfAqACYbUyCpfsLSa9LdA_bgbt5hXDCw~90ca3a75d22ae5726d8766271ba78036

Analyst Recommendations on Luye Pharma Group Ltd.

Luye Pharma's Lung Cancer Injectable Treatment Shows 45% Response Rate in Trial MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
2.518 CNY
Average target price
2.785 CNY
Spread / Average Target
+10.60%
High Price Target
3.65 CNY
Spread / Highest target
+44.97%
Low Price Target
2.221 CNY
Spread / Lowest Target
-11.79%

Consensus detail

Consensus revision (last 18 months)

Ratings for Luye Pharma Group Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2186 Stock
  4. Consensus Luye Pharma Group Ltd.